Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Sleep|April 19, 2017
Cell Death Biomarkers and Obstructive Sleep Apnea: Implications in the Acute Coronary SyndromeJosep Miquel Bauça, Aina Yañez, Laura Fueyo, et al.
Archivos De Bronconeumologia|May 27, 2018
Rationale and Methodology of the SARAH Trial: Long-Term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep ApneaEsther Sapiña-Beltrán, Gerard Torres, Montserrat Martínez-Alonso, et al.
Clinical Biochemistry|April 1, 2019
Biomarker panel in sleep apnea patients after an acute coronary eventJosep Miquel Bauça, Antonia Barcelo, Laura Fueyo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 25, 2021
Effect of CPAP treatment on BP in resistant hypertensive patients according to the BP dipping pattern and the presence of nocturnal hypertensionEsther Sapiña-Beltrán, Iván D Benitez, Gerard Torres, et al.
Annals of the American Thoracic Society|September 14, 2019
Prevalence, Characteristics, and Association of Obstructive Sleep Apnea with Blood Pressure Control in Patients with Resistant HypertensionEsther Sapiña-Beltrán, Gerard Torres, Ivan Benitez, et al.
The European Respiratory Journal|March 10, 2018
Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoeaFernando Santamaria-Martos, Ivan Benítez, Cristina Girón, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 22, 2022
Proteomic profiling for prediction of recurrent cardiovascular event in patients with acute coronary syndrome and obstructive sleep apnea: A post-hoc analysis from the ISAACC studyAndrea Zapater, Esther Gracia-Lavedan, Gerard Torres, et al.
The European Respiratory Journal|September 21, 2023
Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trialLucía Pinilla, Neda Esmaeili, Gonzalo Labarca, et al.
Communications Biology|November 25, 2025
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamstersNúria Pedreño-López, Ferran Tarrés-Freixas, Carla Usai, et al.
Pageof 7